BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 35196966)

  • 1. Structure-based pharmacophore mapping and virtual screening of natural products to identify polypharmacological inhibitor against c-MET/EGFR/VEGFR-2.
    Varma DA; Singh M; Wakode S; Dinesh NE; Vinaik S; Asthana S; Tiwari M
    J Biomol Struct Dyn; 2023 Apr; 41(7):2956-2970. PubMed ID: 35196966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2/G9a).
    Jana A; Naga R; Saha S; Griñán-Ferré C; Banerjee DR
    J Biomol Struct Dyn; 2024 Apr; 42(7):3535-3562. PubMed ID: 37216299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of EGFR inhibitors as potential agents for cancer therapy: pharmacophore-based modeling, molecular docking, and molecular dynamics investigations.
    Ashiru MA; Ogunyemi SO; Temionu OR; Ajibare AC; Cicero-Mfon NC; Ihekuna OA; Jagun MO; Abdulmumin L; Adisa QK; Asibor YE; Okorie CJ; Lawal MO; Babalola MO; Abdulrasaq IT; Salau LB; Olatunji IO; Bankole MA; Daud AB; Adeyemi AO
    J Mol Model; 2023 Apr; 29(5):128. PubMed ID: 37016200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore-based virtual screening and
    Roney M; Huq AKMM; Issahaku AR; Soliman MES; Hossain MS; Mustafa AH; Islam MA; Dubey A; Tufail A; Mohd Aluwi MFF; Tajuddin SN
    J Biomol Struct Dyn; 2023; 41(21):12186-12203. PubMed ID: 36645141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of Novel PDEδ Inhibitor Based on Pharmacophore and Molecular Docking against KRAS Mutant in Colorectal Cancer.
    Mouhcine M; Kadil Y; Rahmoune I; Filali H
    Curr Drug Discov Technol; 2023; 20(4):e160423215830. PubMed ID: 37066770
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Yang Y; Ji C; Zhong Q; Yan H; Wang J
    J Biomol Struct Dyn; 2023 Oct; ():1-14. PubMed ID: 37904331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore modelling-based drug repurposing approaches for monkeypox therapeutics.
    Alagarsamy V; Shyam Sundar P; Raja Solomon V; Narendhar B; Sulthana MT; Rohitha K; Dhanwar S; Dharshini Aishwarya A; Murugesan S
    J Biomol Struct Dyn; 2023 Dec; 41(20):10678-10689. PubMed ID: 36905675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DFT, molecular docking and molecular dynamics simulation studies on some recent natural products revealing their EGFR tyrosine kinase inhibition potential.
    Erdogan T; Oguz Erdogan F
    J Biomol Struct Dyn; 2024 Apr; 42(6):2942-2956. PubMed ID: 37144731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potent EGFR-TKD inhibitors from NPACT database through combined computational approaches.
    Mir SA; Muhammad A; Padhiary A; Ekka NJ; Baitharu I; Naik PK; Nayak B
    J Biomol Struct Dyn; 2023; 41(21):12063-12076. PubMed ID: 36695102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying novel and potent inhibitors of EGFR protein for the drug development against the breast cancer.
    Siddiqui AJ; Jahan S; Patel M; Abdelgadir A; Alturaiki W; Bardakci F; Sachidanandan M; Badraoui R; Snoussi M; Adnan M
    J Biomol Struct Dyn; 2023; 41(23):14460-14472. PubMed ID: 36826428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential inhibitors of tropomyosin receptor kinase B targeting CNS-related disorders and cancers.
    Hakami MA; Alotaibi BS; Hazazi A; Shafie A; Alsaiari AA; Ashour AA; Anjum F
    J Biomol Struct Dyn; 2024 Apr; 42(6):2965-2975. PubMed ID: 37184150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational identification and exploration of novel FGFR tyrosine kinase inhibitors for the treatment of cholangiocarcinoma.
    Kaur A; Mandal D
    J Biomol Struct Dyn; 2023 Oct; ():1-12. PubMed ID: 37897189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore mapping approach to find anti-cancer phytochemicals with metformin-like activities against transforming growth factor (TGF)-beta receptor I kinase: An in silico study.
    Reza R; Morshed N; Samdani MN; Reza MS
    PLoS One; 2023; 18(11):e0288208. PubMed ID: 37943796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Repurposing of a Novel Inhibitor (drug) of EGFR and VEGFR-2 Kinases of Cancer by Pharmacokinetics, Toxicity, Molecular Docking, and Molecular Dynamics Simulation.
    Ibraheim MH; Maher I; Khater I
    Appl Biochem Biotechnol; 2024 May; ():. PubMed ID: 38782800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of DNA Methyltransferase-1 Inhibitor for Breast Cancer Therapy through Computational Fragment-Based Drug Design.
    Alkaff AH; Saragih M; Imana SN; Nasution MAF; Tambunan USF
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33450856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unleashing Nature's potential: a computational approach to discovering novel VEGFR-2 inhibitors from African natural compound using virtual screening, ADMET analysis, molecular dynamics, and MMPBSA calculations.
    Baammi S; El Allali A; Daoud R
    Front Mol Biosci; 2023; 10():1227643. PubMed ID: 37800126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine modulates cardiovascular diseases as a multitarget-mediated alkaloid with insights into its downstream signals using
    Almowallad S; Al-Massabi R
    Saudi J Biol Sci; 2024 May; 31(5):103977. PubMed ID: 38510527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of direct inhibitor of KRAS oncogenic protein by natural products: a combination of pharmacophore search, molecular docking, and molecular dynamic studies.
    Hashemi S; Sharifi A; Zareei S; Mohamedi G; Biglar M; Amanlou M
    Res Pharm Sci; 2020 Jun; 15(3):226-240. PubMed ID: 33088323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potential novel TRPC5 inhibitors by virtual screening and bioassay.
    Shen M; Li L; Li Y; Gu X; Bai L; Xia C; Xiong W; Zuo Z
    Bioorg Med Chem; 2023 Oct; 94():117477. PubMed ID: 37738708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the potential of biologically active phenolic acids from marine natural products as anticancer agents targeting the epidermal growth factor receptor.
    Roney M; Issahaku AR; Huq AM; Soliman MES; Tajuddin SN; Aluwi MFFM
    J Biomol Struct Dyn; 2023 Nov; ():1-24. PubMed ID: 37909584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.